Drug Discovery Technologies
Chairs: | Lorenz Mayr, Novartis Pharma AG (Basel, CH) |
| Gregor Dernick, F. Hoffmann-La Roche Ltd. (Basel, CH) |
Session Summary:
This session will focus on novel technologies to support and enhance the drug discovery process. We will discuss a broad range of enabling technologies covering recent developments in instrumentation, automation, spectroscopy, biophysics, microfluidics and nanotechnologies with a focus on the user's perspective. We intend to look into new applications of established technologies, as well as visionary concepts from both academia and industry.